BioAmber Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2018-10-26: Form 8-K; Period of report 2018-10-25; Description 8.01 Other Events; Details 8.01.
- 2018-09-04: Form 8-K; Period of report 2018-08-28; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2018-08-14: Form 8-K; Period of report 2018-08-09; Description 8.01 Other Events; Details 8.01.
- 2018-08-01: Form 8-K; Period of report 2018-07-30; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2018-10-26 | 8-K | 2018-10-25 | 8.01 Other Events | 8.01 On October 25, 2018, BioAmber Inc. issued a press release entitled “BioAmber Provides Update on Liquidation Process.” A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. | d645901d8k.htm |
| 2018-09-04 | 8-K | 2018-08-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On August 28, 2018, Kurt Briner, Robert Frost, Heinz Haller, Ellen Richstone and Kenneth Wall each resigned from the Board of Directors of BioAmber Inc. (the “Company”), including all committees thereof, and on August 29, 2018, Raymond Land resigned from the Board and all committees thereof. | d614167d8k.htm |
| 2018-08-14 | 8-K | 2018-08-09 | 8.01 Other Events | 8.01 On August 9, 2018, BioAmber Inc. issued a press release entitled “BioAmber Provides Update on Liquidation Process.” A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. | d583988d8k.htm |
| 2018-08-01 | 8-K | 2018-07-30 | 8.01 Other Events | 8.01 On July 30, 2018, BioAmber Inc. issued a press release entitled “BioAmber Provides Update on Sales Process”. | d598473d8k.htm |
| 2018-06-20 | 8-K | 2018-06-18 | 8.01 Other Events | 8.01 On June 18, 2018, BioAmber Inc. issued a press release entitled “BioAmber Receives Favourable Court Ruling and Approval for DIP Financing”. | d618257d8k.htm |
| 2018-05-08 | 8-K | 2018-05-04 | 1.03 Bankruptcy or Receivership | 1.03 On May 4, 2018, BioAmber Inc. (“BioAmber”) (the “Debtor”), filed a voluntary petition (the “Bankruptcy Petition”) for reorganization under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Court”). | d582086d8k.htm |
| 2018-02-16 | 8-K | 2018-02-15 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 7.01 Regulation FD Disclosure | 3.01 On February 15, 2018, BioAmber Inc. (the “Company”) received a letter from the Toronto Stock Exchange (the “TSX”) notifying the Company that it had determined to suspend trading of the Company’s shares of common stock, effective February 16, 2018, and to delist the Company’s securities effective at the close of market on March 16, 2018. 7.01 On February 16, 2018, the Company issued a press release announcing the notice of suspension and delisting by the TSX. | d541046d8k.htm |
| 2018-02-15 | 8-K | 2018-02-13 | 7.01 Regulation FD Disclosure | 7.01 On February 13, 2018, BioAmber Inc. (the “Company”) issued a press release announcing the review by the Toronto Stock Exchange (“TSX”) of the Company’s eligibility for continued listing on the TSX in connection with the approval process for the Company’s registered directed offering announced on February 9, 2018. | d518489d8k.htm |
| 2018-02-13 | 8-K | 2018-02-08 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 1.02 On February 8, 2018, the underwriting agreement for the Company’s underwritten public offering that priced on February 6, 2018 was terminated by the Company’s underwriter for such offering, due to the suspension and potential delisting of the Company’s common stock from the NYSE. 3.01 On February 8, 2018, the New York Stock Exchange, or “NYSE,” notified BioAmber Inc. (the “Company”) that the NYSE has suspended trading in the Company’s common stock, effective immediately, and has commenced proceedings to delist the stock from the NYSE. 7.01 On February 9, 2018, the Company issued a press release announcing the Offering and the termination of its previously announced underwritten public offering. | d520750d8k.htm |
| 2018-02-08 | 8-K | 2018-02-06 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On February 6, 2018, the Company issued a press release announcing the pricing of the Offering. | d522224d8k.htm |
| 2018-02-06 | 8-K/A | 2018-02-05 | 7.01 Regulation FD Disclosure | 7.01 On February 5, 2018, the Company issued a press release announcing a proposed underwritten public offering of shares of its common stock, pre-funded warrants to purchase shares of its common stock and warrants to purchase shares of its common stock (the “Offering”). | d535886d8ka.htm |
| 2018-02-05 | 8-K | 2018-02-05 | 7.01 Regulation FD Disclosure | 7.01 On February 5, 2018, the Company issued a press release announcing a proposed underwritten public offering of shares of its common stock, pre-funded warrants to purchase shares of its common stock and warrants to purchase shares of its common stock (the “Offering”). | d535886d8k.htm |
| 2018-01-26 | 8-K | 2017-09-26 | 1.01 Entry into a Material Definitive Agreement | 1.01 BioAmber Sarnia Inc. (“BioAmber Sarnia”), a subsidiary of BioAmber Inc. (“us,” “we,” or the “Company”) entered into a Waiver and Third Amending Agreement to Loan Agreement with Comerica Bank and the lenders party thereto (the “Third Amending Agreement”) on September 26, 2017, which, among other things, provided for certain waivers and modifications to our Loan Agreement, dated as of June 30, 2014, with Comerica Bank and the lenders party thereto (as amended, the “Loan Agreement”). | d460213d8k.htm |
| 2017-11-08 | 8-K | 2017-11-07 | 2.02 Results of Operations and Financial Condition | bioa-8k_20171107.htm | |
| 2017-10-24 | 8-K | 2017-10-24 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | bioa-8k_20171024.htm | |
| 2017-09-14 | 8-K | 2017-09-11 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 11, 2017, the Board of Directors of BioAmber, Inc. (the “Company”) appointed of Richard Eno as Chief Executive Officer of the Company. | bioa-8k_20170911.htm |
| 2017-09-13 | 8-K | 2017-09-08 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 7.01 Regulation FD Disclosure | bioa-8k_20170908.htm | |
| 2017-08-11 | 8-K | 2017-08-08 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On August 7, 2017, the Company issued a press release announcing the proposed Offering and on August 8, 2017, the Company issued a press release announcing the pricing of the Offering. | bioa-8k_20170808.htm |
| 2017-08-03 | 8-K | 2017-08-01 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.02 Results of Operations and Financial Condition; 8.01 Other Events | bioa-8k_20170801.htm | |
| 2017-05-15 | 8-K | 2017-05-11 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 On May 12, 2017, Robert Frost was appointed by the Board of BioAmber Inc. (the “Company”) to serve as a Class II director, with a term expiring at the Company’s 2018 Annual Meeting of Stockholders. 5.07 The Company held its Annual Meeting of Shareholders on May 11, 2017 in Montreal, Canada (the “Annual Meeting”). | bioa-8k_20170515.htm |
| 2017-05-09 | 8-K | 2017-05-09 | 2.02 Results of Operations and Financial Condition | 2.02 On May 9, 2017, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended March 31, 2017. | bioa-8k_20170509.htm |
| 2017-05-04 | 8-K | 2017-04-27 | 8.01 Other Events | 8.01 On April 27, 2017, BioAmber Inc. filed with the British Columbia Securities Commission a prospectus in connection with its application to list its common stock on the Toronto Stock Exchange. | bioa-8k_20170427.htm |
| 2017-03-31 | 8-K | 2017-03-28 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On March 31, 2017, BioAmber Inc. (the “Company”) entered into a Mutual Separation Agreement with Mario Saucier (the “Separation Agreement”) effective March 28, 2017 (the “Separation Date”). 5.02 On March 28, 2017, the Board of Directors of the Company and Mario Saucier mutually agreed that Mr. Saucier would cease serving in his role as Chief Financial Officer of the Company, as of the Separation Date. | bioa-8k_20170328.htm |
| 2017-03-16 | 8-K | 2017-03-16 | 2.02 Results of Operations and Financial Condition | 2.02 On March 16, 2017, BioAmber Inc. issued a press release announcing its preliminary financial results for the year ended December 31, 2016. | bioa-8k_20161231.htm |
| 2017-02-21 | 8-K | 2017-02-17 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | bioa-8k_20170221.htm | |
| 2017-01-30 | 8-K | 2017-01-27 | 1.02 Termination of a Material Definitive Agreement | 1.02 On January 27, 2017, the Company paid off and terminated its demand non-revolving credit facility agreement (the “Facility Agreement”) with Bridging Finance Inc. The Company reimbursed the CDN$ 25 million principal owed, as well as accrued and unpaid interest and fees. | bioa-8k_20170127.htm |
| 2017-01-27 | 8-K | 2017-01-23 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | bioa-8k_20170123.htm |
| 2017-01-23 | 8-K | 2017-01-23 | 8.01 Other Events | 8.01 On January 23, 2017, BioAmber Inc. issued a press release entitled “BioAmber Inc. Announces US $10 Million Underwritten Offering.” A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. | d332966d8k.htm |
| 2016-12-29 | 8-K | 2016-12-22 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d274028d8k.htm |
| 2016-12-23 | 8-K | 2016-12-23 | 7.01 Regulation FD Disclosure | 7.01 On December 23, 2016, BioAmber Inc. (the “Company” or “we”) filed two prospectus supplements to the base prospectus included in the Company’s shelf registration statement on Form S-3 (No. 333-196470), filed with the Securities and Exchange Commission on June 2, 2014. | d320052d8k.htm |
| 2016-11-07 | 8-K | 2016-11-03 | 2.02 Results of Operations and Financial Condition | 2.02 On November 3, 2016, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended September 30, 2016. | bioa-8k_20161103.htm |
| 2016-09-14 | 8-K | 2016-09-09 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.02 On September 9, 2016, the Company voluntarily paid off and terminated its Loan and Security Agreement with Tennenbaum Capital Partner, LLC (the “Loan and Security Agreement”). 2.03 The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03. | bioa-8k_20160909.htm |
| 2016-08-09 | 8-K/A | 2016-04-20 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 2.03 The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03. | bioa-8ka_20160420.htm |
| 2016-08-09 | 8-K | 2016-08-09 | 2.02 Results of Operations and Financial Condition | 2.02 On August 9, 2016, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended June 30, 2016. | bioa-8k_20160809.htm |
| 2016-05-23 | 8-K | 2016-05-19 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 BioAmber Inc. (the “Company”) held its Annual Meeting of Shareholders on May 19, 2016 in New York, New York (the “Annual Meeting”). | bioa-8k_20160519.htm |
| 2016-05-03 | 8-K | 2016-05-03 | 2.02 Results of Operations and Financial Condition | 2.02 On May 3, 2016, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended March 31, 2016. | bioa-8k_20160503.htm |
| 2016-04-26 | 8-K | 2016-04-20 | 1.01 Entry into a Material Definitive Agreement | bioa-8k_20160420.htm | |
| 2016-03-14 | 8-K | 2016-03-14 | 2.02 Results of Operations and Financial Condition | 2.02 On March 14, 2016, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months and the year ended December 31, 2015. | bioa-8k_20151104.htm |
| 2016-02-26 | 8-K | 2016-02-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 22, 2016, Henry Linsert, Jr. resigned from his position as a member of the Board of Directors (the “Board”) of BioAmber Inc. (the “Company”), effective immediately, for personal reasons unrelated to the Company’s operations, policies or practices. | bioa-8k_20160222.htm |
| 2016-02-12 | 8-K | 2016-02-08 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On February 12, 2016, BioAmber announced that Ms. Babette Pettersen, Chief Commercial Officer, was stepping down from her position, effective immediately. | bioa-8k_20160208.htm |
| 2016-01-19 | 8-K | 2016-01-15 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d123143d8k.htm |
| 2015-12-28 | 8-K | 2015-12-28 | 8.01 Other Events | 8.01 On December 28, 2015, Euronext Paris S.A. (“Euronext”) announced that its board of directors had approved a request by BioAmber Inc. (the “Company”) to delist. | bioa-8k_20151228.htm |
| 2015-12-18 | 8-K | 2015-12-14 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | bioa-8k_20151214.htm |
| 2015-12-17 | 8-K | 2015-12-16 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 Please see the discussion in “Item 1.01 Entry into a Material Definitive Agreement” of this Current Report on Form 8-K, which discussion is incorporated herein by reference. | bioa-8k_20151216.htm |
| 2015-11-17 | 8-K | 2015-11-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On November 16, 2015, BioAmber Inc. (the “Company”) announced that Mario Saucier, 49 , has been appointed as the Company’s Chief Financial Officer effective as of January 4, 2016. | bioa-8k_20151116.htm |
| 2015-11-04 | 8-K | 2015-11-04 | 2.02 Results of Operations and Financial Condition | 2.02 On November 4, 2015, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended September 30, 2015. | bioa-8k_20151104.htm |
| 2015-08-04 | 8-K | 2014-07-29 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 Please see the discussion in “Item 1.01 Entry into a Material Definitive Agreement” of this Current Report on Form 8-K, which discussion is incorporated herein by reference. | bioa-8k_20140729.htm |
| 2015-08-04 | 8-K | 2015-08-04 | 2.02 Results of Operations and Financial Condition | 2.02 On August 4, 2015, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended June 30, 2015. | bioa-8k_20150804.htm |
| 2015-07-29 | 8-K | 2015-07-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On July 29, 2015, BioAmber Inc. (the “Company”) announced that François Laurin, its Chief Financial Officer, has resigned. | bioa-8k_20150729.htm |
| 2015-05-19 | 8-K | 2015-05-15 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 BioAmber Inc. (the “Company”) held its Annual Meeting of Shareholders on May 15, 2015 in Sarnia, Ontario, Canada (the “Annual Meeting”). | bioa-8k_20150515.htm |
| 2015-05-19 | 8-K | 2014-05-06 | 8.01 Other Events | 8.01 As previously disclosed in our Form 10-Q for the fiscal quarter ended March 31, 2015 filed on May 11, 2015, on May 6, 2015, BioAmber Inc. (“BioAmber” or the “Company”) completed the initial closingof a follow-on public offering and issued 3,900,000 shares of common stock, at an offering price to the public of $9.00 per share. | bioa-8k_20140506.htm |
| 2015-05-07 | 8-K | 2015-05-07 | 2.02 Results of Operations and Financial Condition | 2.02 On May 7, 2015, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended March 31, 2015. | bioa-8k_20150507.htm |
| 2015-05-04 | 8-K | 2015-05-01 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On April 30, 2015, the Company issued a press release announcing the Offering. | d918073d8k.htm |
| 2015-03-12 | 8-K | 2015-03-12 | 2.02 Results of Operations and Financial Condition | 2.02 On March 12, 2015, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended December 31, 2014 and the year ended December 31, 2014. | bioa-8k_20150312.htm |
| 2015-01-06 | 8-K | 2015-01-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 6, 2015, BioAmber Inc. (the “Company”) issued a press release announcing that Chief Financial Officer Andrew Ashworth retired on December 31, 2014. | bioa-8k_20150501.htm |
| 2014-12-19 | 8-K | 2014-12-19 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 1.02 On December 17, 2014, the Company voluntarily paid off and terminated the Hercules Agreement. 2.03 The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03. | bioa-8k_20140111.htm |
| 2014-11-06 | 8-K | 2014-11-06 | 2.02 Results of Operations and Financial Condition | 2.02 On November 6, 2014, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended September 30, 2014. | bioa-8k_20140611.htm |
| 2014-08-07 | 8-K | 2014-08-07 | 2.02 Results of Operations and Financial Condition | 2.02 On August 7, 2014, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended June 30, 2014. | bioa-8k_20140708.htm |
| 2014-07-21 | 8-K | 2014-07-16 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d758791d8k.htm |
| 2014-07-15 | 8-K | 2014-07-15 | 7.01 Regulation FD Disclosure | 7.01 On July 15, 2014, BioAmber Inc. (the “Company”) filed a preliminary prospectus supplement to the base prospectus included in the Company’s shelf registration statement on Form S-3 (No. 333-196470), filed with the SEC on June 2, 2014. | d756956d8k.htm |
| 2014-06-25 | 8-K | 2014-06-20 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03. | d747076d8k.htm |
| 2014-05-29 | 8-K | 2014-05-27 | 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events | 5.07 BioAmber Inc. held its Annual Meeting of Shareholders on May 27, 2014 in New York, New York (the “Annual Meeting”). 8.01 Following the Annual Meeting, the Board of Directors of the Company (the “Board”) made certain appointments to its Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, as described below. | d734732d8k.htm |
| 2014-05-08 | 8-K | 2014-05-08 | 2.02 Results of Operations and Financial Condition | 2.02 On May 8, 2014, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended March 31, 2014. | d725242d8k.htm |
| 2014-03-13 | 8-K | 2014-03-13 | 2.02 Results of Operations and Financial Condition | 2.02 On March 13, 2014, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months and the year ended December 31, 2013. | d695103d8k.htm |
| 2014-02-18 | 8-K | 2014-02-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 14, 2014, William Camp resigned from his position as a Director of BioAmber Inc. (the Company). | d679524d8k.htm |
| 2014-01-03 | 8-K | 2014-01-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 2, 2014, BioAmber Inc. (the “Company”) appointed Fabrice Orecchioni to serve as an Officer of the Company. | d651462d8k.htm |
| 2013-11-07 | 8-K | 2013-11-07 | 2.02 Results of Operations and Financial Condition | 2.02 On November 7, 2013, BioAmber Inc. issued a press release announcing its preliminary financial results for the three months ended September 30, 2013. | d624389d8k.htm |
| 2013-08-28 | 8-K | 2013-08-27 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 BioAmber Inc. (the “Company”) announced that on August 27, 2013, Kenneth W. Wall was elected to the Board of Directors of the Company. | d590789d8k.htm |
| 2013-08-12 | 8-K | 2013-08-12 | 2.02 Results of Operations and Financial Condition | 2.02 On August 12, 2013, BioAmber Inc. issued a press release announcing its preliminary financial results for the quarter ended June 30, 2013. | d583283d8k.htm |
| 2013-06-28 | 8-K | 2013-06-27 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03. | d562074d8k.htm |
| 2013-06-10 | 8-K | 2013-06-10 | 8.01 Other Events | 8.01 BioAmber Inc. (the “Company”) announced today that on June 10, 2013, the French Autorité des marchés financiers approved the Company’s prospectus for admission of its common stock to listing and trading on the Professional Segment of NYSE Euronext Paris under the symbol “BIOA.” The Company’s common stock will commence trading on the NYSE Euronext Paris on June 11, 2013. | d552074d8k.htm |
| 2013-06-03 | 8-K | 2013-06-03 | 8.01 Other Events | 8.01 BioAmber Inc. (the “Company”) announced today that, commencing on June 10, 2013, the common stock and warrants comprising the Company’s units issued in its initial public offering will begin trading separately on the New York Stock Exchange (“NYSE”) under the symbols “BIOA” and “BIOA.WS”, respectively. | d549309d8k.htm |